Close Menu

Quidel

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared the Quidel Molecular Direct C.

Quidel said this week that it has received 510(k) clearance from the US Food and Drug Administration for its Quidel Molecular RSV + hMPV assay for the detection of respiratory syncytial virus and human metapneumovirus.

NEW YORK (GenomeWeb News) – Quidel has received US Food and Drug Administration 510(k) clearance to market its molecular respiratory viral panel in the US, the company said on Tuesday.

Quidel disclosed this week that it has been awarded a milestone-based grant from the Bill and Melinda Gates Foundation to support the development, validation, and manufacture of a low-cost quantitative nucleic acid test to monitor HIV drug treatment.

NEW YORK (GenomeWeb News) – An early and severe flu season drove Quidel's fourth-quarter revenues up 40 percent year over year, the company reported after the close of the market on Tuesday.

Life Technologies this week reported a 2 percent increase in fourth-quarter revenues amid flat full-year revenues for its Genetic Analysis business unit, which includes the company's PCR and CE research instruments, sequencing products, and associated consumables.

This story has been updated from a previous version to clarify Exact Sciences' FDA submission timeline.

NEW YORK (GenomeWeb News) – Quidel today said that it expects to report fourth-quarter revenues of $53 million to $54 million.
That figure is well above Wall Street's consensus estimate for revenues of $43.8 million.

NEW YORK (GenomeWeb News) – Raymond James Equity Research today upgraded Quidel to Outperform and established a price target of $22, noting expected new products throughout the year that should expand the company's revenue base.

Quidel this week received 510(k) clearance from the US Food and Drug Administration for its AmpliVue C. Difficile assay.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.